A carregar...

The diffuse large B-cell lymphoma – where do we stand now in everyday clinical practice

BACKGROUND: Due to superior results observed with the addition of rituximab into treatment of patients with the diffuse large B-cell lymphoma (DLBCL),the R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) regimen and its variants became the standard initial treatment of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gregoric, Brigita, Zadnik, Vesna, Jezersek Novakovic, Barbara
Formato: Artigo
Idioma:Inglês
Publicado em: Versita, Warsaw 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472942/
https://ncbi.nlm.nih.gov/pubmed/23077452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/v10019-012-0002-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!